Antihypertensive AgentsHypertensionRenal DialysisBlood PressureHydrochlorothiazideKidney Failure, ChronicDiureticsAngiotensin-Converting Enzyme InhibitorsAtenololAmlodipineCalcium Channel BlockersHydralazineMethyldopaHemodialysis, HomeSodium Chloride Symporter InhibitorsAdrenergic beta-AntagonistsMinoxidilBendroflumethiazideRats, Inbred SHRDoxazosinHemodialysis Units, HospitalAngiotensin II Type 1 Receptor BlockersCaptoprilTetrazolesLisinoprilNordefrinHemodialysis SolutionsGlutamyl AminopeptidaseArteriovenous Shunt, SurgicalDihydropyridinesAngiotensin Receptor AntagonistsTreatment OutcomeClonidineEnalaprilBlood Pressure Monitoring, AmbulatoryIndapamideDrug Therapy, CombinationLabetalolGuanfacineHypertension, RenalBlood Pressure DeterminationTime FactorsPerindoprilRenin-Angiotensin SystemBenzimidazolesNifedipineHeart RateImidazoline ReceptorsReninPropanolaminesLosartanDiltiazemRisk FactorsDouble-Blind MethodProspective StudiesUremiaPrazosinRats, Inbred WKYPatient ComplianceKidney DiseasesChlorthalidoneFollow-Up StudiesCatheters, IndwellingSystoleDose-Response Relationship, DrugDiabetic NephropathiesAdrenergic alpha-AntagonistsCardiovascular DiseasesFumaratesKidneyBiphenyl CompoundsMedication AdherenceClinical Trials as TopicPropranololImidazolesKidneys, ArtificialValineDesoxycorticosteroneHypertension, RenovascularCreatinineHemodynamicsDrug CombinationsPhenylacetatesRetrospective StudiesDiabetes ComplicationsAdministration, OralBenzopyransArteriesRisk AssessmentPeritoneal DialysisCardiovascular SystemProteinuriaDiabetes Mellitus, Type 2Randomized Controlled Trials as TopicTrichlormethiazideHemodiafiltrationDelayed-Action PreparationsHypertrophy, Left VentricularThiazidesAorta